Search results for: 'complex need'

In an era of precision medicine and precision health, women deserve to receive gender-specific healthcare. The side-effects of the pandemic, like prolonged homestay induced by lockdowns, have disproportionately impacted women who have experienced a higher burden of household chores, increased anxiety and depression, etc., leading to a dramatic incr...

The global enterprise medical imaging workflow orchestration solutions industry is undergoing rapid changes because of new technological developments, new clinical and administrative needs, and the introduction of new policies and regulations, making it necessary for industry participants to innovate to maintain a competitive edge. The healthca...

Globally, the difficulty in operating large hospitals is made worse by use of manual operations and processes that often lead to a host of inefficiencies. The COVID-19 pandemic in the first half of 2020 brought these inefficiencies to the fore, and as a lasting impact, hospitals must now address the backlog of outpatient, imaging, and surgery patie...

23 Oct 2020  |  North America  |  Market Research

Access to New Therapy Areas to Drive Major Growth in the Global Biosimilars Market, 2020–2026

Outsourced Manufacturing of the Complex Third Wave of Biosimilars to Spark New Growth Opportunities

Infographics

×

Key Issues Addressed

In this research service, the Transformational Health team at Frost & Sullivan provides critical insights into the global biosimilar industry, highlighting the key growth opportunities, market revenue forecasts, and trends that will influence the industry with the emergence of the third wave of biosimilars. The global third-wave biosimilars market ...

The global biopharma patient access market is undergoing a structural shift as specialty medicines make downstream commercialization more complex and strategically important. Patient access is no longer limited to reimbursement support or hub services; it is becoming a commercialization control layer spanning authorization, affordability, therapy i...

The global pharmaceutical market is projected to reach approximately $1.72 trillion in 2026, with large molecules driving most incremental growth while small molecules remain the sector’s cash flow base. The current growth cycle concentrates on cardiometabolic and oncology, led by GLP-1 platforms and antibody–drug conjugates (ADCs). Competitive adv...

The tissue sealants and topical hemostats market in Western Europe is highly complex and there exists a significant overlap in product segmentation, positioning, and end-user applications. As the applicability of tissue sealants and topical hemostats, as far as the number of surgical procedures increases, the market for these products is expected t...

The study on the "Global Biologics Contract Development & Manufacturing Organizations (CDMO) Market: Companies-to-Action" presents an overview of the global biologics development and manufacturing landscape with an emphasis on the seven leading CDMOs in the market. The study highlights the shifting focus and investments of bio-pharma companies towa...

13 Sep 2021  |  North America  |  Market Research

Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities

Emerging Pharmaceuticals and Highly Potent Complex Molecules Creating Future Growth Potential

Infographics

×

This study presents Frost & Sullivan’s overall market and segment-wise revenue forecasts of the global small molecule contract development and manufacturing organization (CDMO) industry. It highlights key growth opportunities for small molecule CDMOs based on the main evolution in their business models and strategic approaches as well as those of p...